Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus.

about

Toxicology of autoimmune diseases.Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus.Autoantibody Profiling in Lupus Patients using Synthetic Nucleic Acids.Drug-induced lupus: an update

P2860

Q34788943-884E7D40-24E5-4D1E-8F77-0D9627FDC5F7 Q42518061-382D7EA8-78BB-495D-8B06-7422601B4DB8 Q52721879-8BC599E2-44CA-4E3A-820E-C896E83F8631 Q56224756-B90A6389-37FD-4BFB-8EEF-C6B3927223FE

P2860

Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus.

Item

http://www.wikidata.org/entity/Q47398030

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Complement-fixing properties o ...... systemic lupus erythematosus.

@en

Complement-fixing properties o ...... systemic lupus erythematosus.

@nl

type

Item

label

Complement-fixing properties o ...... systemic lupus erythematosus.

@en

Complement-fixing properties o ...... systemic lupus erythematosus.

@nl

prefLabel

Complement-fixing properties o ...... systemic lupus erythematosus.

@en

Complement-fixing properties o ...... systemic lupus erythematosus.

@nl

P1476

Complement-fixing properties o ...... systemic lupus erythematosus.

@en

P2093

E H Beutner

http://www.w3.org/2001/XMLSchema#string

M Teodorescu

http://www.w3.org/2001/XMLSchema#string

R L Rubin

http://www.w3.org/2001/XMLSchema#string

R W Plunkett

http://www.w3.org/2001/XMLSchema#string

P2860

The Relation of Immunoglobulin Class, Pattern of Antinuclear Antibody, and Complement-Fixing Antibodies to DNA in Sera from Patients with Systemic Lupus Erythematosus*

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

IgG Fc receptors

Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.

Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

Assessment of systemic lupus erythematosus disease activity by medical record review compared with direct standardized evaluation.

Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.

Immunologic factors and clinical activity in systemic lupus erythematosus.

P304

249-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/0961203304LU1007OA

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15176661

http://www.w3.org/2001/XMLSchema#string

Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus.

about

P2860

P2860

Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698